Predicting survival in metastatic non‐small cell lung cancer patients with poor ECOG‐PS: A single‐arm prospective study

Abstract Background Patients with advanced non‐small cell lung cancer (NSCLC) are a heterogeneous population with short lifespan. We aimed to develop methods to better differentiate patients whose survival was >90 days. Methods We evaluated 83 characteristics of 106 treatment‐naïve, stage IV NSCL...

Full description

Bibliographic Details
Main Authors: Mateus Trinconi Cunha, Ana Paula deSouza Borges, Vinicius Carvalho Jardim, André Fujita, Gilberto deCastro Jr
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.5254
_version_ 1797893166044545024
author Mateus Trinconi Cunha
Ana Paula deSouza Borges
Vinicius Carvalho Jardim
André Fujita
Gilberto deCastro Jr
author_facet Mateus Trinconi Cunha
Ana Paula deSouza Borges
Vinicius Carvalho Jardim
André Fujita
Gilberto deCastro Jr
author_sort Mateus Trinconi Cunha
collection DOAJ
description Abstract Background Patients with advanced non‐small cell lung cancer (NSCLC) are a heterogeneous population with short lifespan. We aimed to develop methods to better differentiate patients whose survival was >90 days. Methods We evaluated 83 characteristics of 106 treatment‐naïve, stage IV NSCLC patients with Eastern Cooperative Oncology Group Performance Status (ECOG‐PS) >1. Automated machine learning was used to select a model and optimize hyperparameters. 100‐fold bootstrapping was performed for dimensionality reduction for a second (“lite”) model. Performance was measured by C‐statistic and accuracy metrics in an out‐of‐sample validation cohort. The “lite” model was validated on a second independent, prospective cohort (N = 42). Network analysis (NA) was performed to evaluate the differences in centrality and connectivity of features. Results The selected method was ExtraTrees Classifier, with C‐statistic of 0.82 (p < 0.01) and accuracy of 0.81 (p = 0.01). The “lite” model had 16 variables and obtained C‐statistic of 0.84 (p < 0.01) and accuracy of 0.75 (p = 0.039) in the first cohort, and C‐statistic of 0.706 (p < 0.01) and accuracy of 0.714 (p < 0.01) in the second cohort. The networks of patients with lower survival were more interconnected. Features related to cachexia, inflammation, and quality of life had statistically different prestige scores in NA. Conclusions Machine learning can assist in the prognostic evaluation of advanced NSCLC. The model generated with a reduced number of features showed high accessibility and reasonable metrics. Features related to quality of life, cachexia, and performance status had increased correlation and importance scores, suggesting that they play a role at later disease stages, in line with the biological rationale already described.
first_indexed 2024-04-10T06:49:44Z
format Article
id doaj.art-a50ac89d77c04dc8a9a4ba96718e3931
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-04-10T06:49:44Z
publishDate 2023-02-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-a50ac89d77c04dc8a9a4ba96718e39312023-02-28T08:51:58ZengWileyCancer Medicine2045-76342023-02-011245099510910.1002/cam4.5254Predicting survival in metastatic non‐small cell lung cancer patients with poor ECOG‐PS: A single‐arm prospective studyMateus Trinconi Cunha0Ana Paula deSouza Borges1Vinicius Carvalho Jardim2André Fujita3Gilberto deCastro Jr4Serviço de Oncologia Clínica, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas HCFMUSP, Faculdade de Medicina Universidade de São Paulo São Paulo BrazilFaculdade de Medicina FMUSP Universidade de São Paulo São Paulo BrazilDepartamento de Ciência da Computação, Instituto de Matemática e Estatística Universidade de São Paulo São Paulo BrazilDepartamento de Ciência da Computação, Instituto de Matemática e Estatística Universidade de São Paulo São Paulo BrazilServiço de Oncologia Clínica, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas HCFMUSP, Faculdade de Medicina Universidade de São Paulo São Paulo BrazilAbstract Background Patients with advanced non‐small cell lung cancer (NSCLC) are a heterogeneous population with short lifespan. We aimed to develop methods to better differentiate patients whose survival was >90 days. Methods We evaluated 83 characteristics of 106 treatment‐naïve, stage IV NSCLC patients with Eastern Cooperative Oncology Group Performance Status (ECOG‐PS) >1. Automated machine learning was used to select a model and optimize hyperparameters. 100‐fold bootstrapping was performed for dimensionality reduction for a second (“lite”) model. Performance was measured by C‐statistic and accuracy metrics in an out‐of‐sample validation cohort. The “lite” model was validated on a second independent, prospective cohort (N = 42). Network analysis (NA) was performed to evaluate the differences in centrality and connectivity of features. Results The selected method was ExtraTrees Classifier, with C‐statistic of 0.82 (p < 0.01) and accuracy of 0.81 (p = 0.01). The “lite” model had 16 variables and obtained C‐statistic of 0.84 (p < 0.01) and accuracy of 0.75 (p = 0.039) in the first cohort, and C‐statistic of 0.706 (p < 0.01) and accuracy of 0.714 (p < 0.01) in the second cohort. The networks of patients with lower survival were more interconnected. Features related to cachexia, inflammation, and quality of life had statistically different prestige scores in NA. Conclusions Machine learning can assist in the prognostic evaluation of advanced NSCLC. The model generated with a reduced number of features showed high accessibility and reasonable metrics. Features related to quality of life, cachexia, and performance status had increased correlation and importance scores, suggesting that they play a role at later disease stages, in line with the biological rationale already described.https://doi.org/10.1002/cam4.5254machine learningnetwork analysisnon‐small cell lung cancerpoor performance statusprognostic markers
spellingShingle Mateus Trinconi Cunha
Ana Paula deSouza Borges
Vinicius Carvalho Jardim
André Fujita
Gilberto deCastro Jr
Predicting survival in metastatic non‐small cell lung cancer patients with poor ECOG‐PS: A single‐arm prospective study
Cancer Medicine
machine learning
network analysis
non‐small cell lung cancer
poor performance status
prognostic markers
title Predicting survival in metastatic non‐small cell lung cancer patients with poor ECOG‐PS: A single‐arm prospective study
title_full Predicting survival in metastatic non‐small cell lung cancer patients with poor ECOG‐PS: A single‐arm prospective study
title_fullStr Predicting survival in metastatic non‐small cell lung cancer patients with poor ECOG‐PS: A single‐arm prospective study
title_full_unstemmed Predicting survival in metastatic non‐small cell lung cancer patients with poor ECOG‐PS: A single‐arm prospective study
title_short Predicting survival in metastatic non‐small cell lung cancer patients with poor ECOG‐PS: A single‐arm prospective study
title_sort predicting survival in metastatic non small cell lung cancer patients with poor ecog ps a single arm prospective study
topic machine learning
network analysis
non‐small cell lung cancer
poor performance status
prognostic markers
url https://doi.org/10.1002/cam4.5254
work_keys_str_mv AT mateustrinconicunha predictingsurvivalinmetastaticnonsmallcelllungcancerpatientswithpoorecogpsasinglearmprospectivestudy
AT anapauladesouzaborges predictingsurvivalinmetastaticnonsmallcelllungcancerpatientswithpoorecogpsasinglearmprospectivestudy
AT viniciuscarvalhojardim predictingsurvivalinmetastaticnonsmallcelllungcancerpatientswithpoorecogpsasinglearmprospectivestudy
AT andrefujita predictingsurvivalinmetastaticnonsmallcelllungcancerpatientswithpoorecogpsasinglearmprospectivestudy
AT gilbertodecastrojr predictingsurvivalinmetastaticnonsmallcelllungcancerpatientswithpoorecogpsasinglearmprospectivestudy